Spain investigating woman’s death two weeks after dose of AstraZeneca Covid-19 vaccine

Spanish health authorities say they are investigating the death of a 43-year-old woman who died on Tuesday after receiving her first dose of AstraZeneca vaccine, as well as two other cases of blood-clotting among recipients. The woman, who lived in Marbella, was reportedly in good health before receiving the vaccine, but fell ill hours after her first dose on March 2. She twice visited emergency clinics over the following 10 days, before a CT scan showed a brain hemorrhage, according to local reports. She underwent surgery but died on Tuesday, and an autopsy will be carried out to determine the specific cause of her illness and death. The government suspended Spain’s rollout of the Oxford/AstraZeneca Covid vaccine on Monday for two weeks while its regulators and the European Medicines Agency (EMA) investigate a fatality in each of Denmark and Austria, as well as reports of blood-clotting in a small number of people who had received the jab.